The Cure Wasn’t The End, It Was The Beginning | Emily Whitehead & Tom Whitehead | TEDxFargo

Quick Overview

Emily Whitehead, the first pediatric patient cured with CAR T-cell therapy, shares her story alongside her father, Tom Whitehead, detailing her initial diagnosis of acute lymphoblastic leukemia, the subsequent relapse, the experimental treatment, and her subsequent thriving life as a college student advocating for pediatric cancer research.

Key Points: Emily Whitehead was the world's first pediatric patient successfully treated with CAR T-cell therapy for acute lymphoblastic leukemia (ALL) in 2012. After 22 months of standard chemotherapy failed to keep her in remission following a relapse in October 2011, Emily received the CAR T-cell therapy and went into remission 23 days later. The initial prognosis after her second relapse was dire, with doctors suggesting hospice care and possible amputation of her legs due to infection. Following her successful treatment, Emily met President Obama, who wrote her an excuse note for missing school, stating, "Please excuse Emily from school - she was with me!" Emily advocates for continued research and funding for less toxic cancer treatments and mental health support for young cancer survivors. Emily is currently thriving as a college student at the University of Pennsylvania, majoring in English and minoring in Creative Writing and Photography.

Context: This TEDxFargo talk features Tom and Emily Whitehead sharing the incredible journey of Emily's battle with acute lymphoblastic leukemia (ALL). Emily was diagnosed at age five, suffered a relapse, and ultimately became the first pediatric patient to be successfully treated with the then-experimental CAR T-cell therapy in 2012, leading to her recovery and subsequent advocacy work.

Detailed Analysis

Tom Whitehead introduced the story, detailing Emily's diagnosis in May 2010 with acute lymphoblastic leukemia (ALL), a common yet potentially curable childhood cancer. After 22 months of chemotherapy failed to maintain remission following a relapse in October 2011, the family faced grim possibilities, including hospice care and amputation. They opted for the experimental CAR T-cell therapy trial at Children's Hospital of Philadelphia, which involved extracting Emily's T-cells, genetically modifying them to attack cancer cells, and reinfusing 60% of them back into her system. Within 23 days of the infusion (April 17, 2012), Emily went into remission and was cancer-free 14 days later. Tom recounted the positive outcomes, noting the CAR T-cells could kill thousands of tumor cells. Emily then spoke, sharing that she was put on the cover of The New York Times as a pioneer for this new treatment, met President Obama (who gave her an excuse note for school), and is now thriving as a college student majoring in English at UPenn. Emily stressed the importance of continued research for less toxic treatments and robust mental health support for survivors, emphasizing that survival does not mean the fight ends.